Vaccine-short Africa is hopeful of getting more COVID-19 doses, as a South African pharmaceutical firm is close to being the first in Africa to distribute
This week has seen a surge in coronavirus cases in Africa due to the new omicron variant. The continent reported 52,000 cases for the week, and 31,000 were reported in South Africa
South Africa's Aspen Pharmacare took a step towards a licensing deal to package and sell Johnson & Johnson's COVID-19 vaccine in Africa, announcing on Tuesday it had signed non-binding terms with subsidiaries of the U.S. drugmaker.